Details for New Drug Application (NDA): 078062
✉ Email this page to a colleague
The generic ingredient in CIPROFLOXACIN is ciprofloxacin hydrochloride. There are thirty-four drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the ciprofloxacin hydrochloride profile page.
Summary for 078062
Tradename: | CIPROFLOXACIN |
Applicant: | Baxter Hlthcare Corp |
Ingredient: | ciprofloxacin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 078062
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 200MG/20ML (10MG/ML) | ||||
Approval Date: | Apr 29, 2008 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 400MG/40ML (10MG/ML) | ||||
Approval Date: | Apr 29, 2008 | TE: | AP | RLD: | No |
Complete Access Available with Subscription